Adhesion molecules like ICAM-1 on multiple myeloma cells increase the binding capacity to BMSCs and overexpression of ICAM-1 have been associated with more advanced disease and drug resistance [11–13]. The gene discussed is ICAM1; the disease is AL amyloidosis.